NO20062579L - Preparater som omfatter melittin-avledede peptider og fremgangsmate for styrking av immunresponser mot malantigener - Google Patents
Preparater som omfatter melittin-avledede peptider og fremgangsmate for styrking av immunresponser mot malantigenerInfo
- Publication number
- NO20062579L NO20062579L NO20062579A NO20062579A NO20062579L NO 20062579 L NO20062579 L NO 20062579L NO 20062579 A NO20062579 A NO 20062579A NO 20062579 A NO20062579 A NO 20062579A NO 20062579 L NO20062579 L NO 20062579L
- Authority
- NO
- Norway
- Prior art keywords
- immune responses
- malantigens
- melittin
- compositions
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
- C07K14/43572—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from bees
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Insects & Arthropods (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51750203P | 2003-11-05 | 2003-11-05 | |
PCT/EP2004/012548 WO2005049647A2 (en) | 2003-11-05 | 2004-11-05 | Compositions comprising melittin-derved peptides and methods for the potentiation of immune responses against target antigens |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20062579L true NO20062579L (no) | 2006-06-02 |
Family
ID=34619323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20062579A NO20062579L (no) | 2003-11-05 | 2006-06-02 | Preparater som omfatter melittin-avledede peptider og fremgangsmate for styrking av immunresponser mot malantigener |
Country Status (8)
Country | Link |
---|---|
US (1) | US7538083B2 (de) |
EP (1) | EP1680446B1 (de) |
AT (1) | ATE377023T1 (de) |
AU (1) | AU2004291277A1 (de) |
CA (1) | CA2543072A1 (de) |
DE (1) | DE602004009818T2 (de) |
NO (1) | NO20062579L (de) |
WO (1) | WO2005049647A2 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7538083B2 (en) * | 2003-11-05 | 2009-05-26 | Intercell Ag | Compositions and methods for the potentiation of immune responses against target antigens |
WO2007092315A2 (en) * | 2006-02-03 | 2007-08-16 | The Regents Of The University Of California | Immunostimulation by cpg oligonucleotide-virus complexes |
WO2007099387A1 (en) | 2006-03-03 | 2007-09-07 | Mymetics Corporation | Virosome-like vesicles comprising gp41-derived antigens |
US20090022799A1 (en) * | 2006-10-06 | 2009-01-22 | Shikha Pramanik Barman | Compositions that contain beta-glucan to be used for the prevention and treatment of disease and methods for their use |
EP2086321B1 (de) | 2006-11-16 | 2016-08-31 | Kai Pharmaceuticals, Inc. | Polykationische kalzium-modulatorpeptide zur behandlung von hyperparathyroidismus und hyperkalzämie-erkrankungen |
EP4154900A1 (de) | 2009-07-29 | 2023-03-29 | Kai Pharmaceuticals, Inc. | Therapiemittel zur reduzierung der nebenschilddrüsenhormonspiegel |
EP2717896B1 (de) | 2011-06-08 | 2016-08-24 | Kai Pharmaceuticals, Inc. | Therapeutika zur regulierung des phosphatgehalts im serum |
CN108129560B (zh) * | 2017-12-15 | 2020-04-28 | 西安交通大学医学院第一附属医院 | 一种突变蜂毒肽MEL-pep及其应用 |
AU2018382419A1 (en) * | 2017-12-15 | 2020-06-04 | Bayer Animal Health Gmbh | Immunostimulatory oligonucleotides |
AU2019264092B2 (en) * | 2018-05-04 | 2024-02-15 | Twinpigbiolab. Inc. | Targeting M2-like tumor-associated macrophages by using melittin-based pro-apoptotic peptide |
CN114288404A (zh) * | 2021-12-20 | 2022-04-08 | 浙江洪晟生物科技股份有限公司 | 一种禽苗用免疫增强剂、二联灭活疫苗及其制备方法和应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683291A (en) * | 1985-10-28 | 1987-07-28 | Scripps Clinic And Research Foundation | Platelet binding inhibitors |
US5268454A (en) * | 1991-02-08 | 1993-12-07 | La Jolla Pharmaceutical Company | Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier |
US5235038A (en) * | 1991-01-22 | 1993-08-10 | Torry Pines Institute For Molecular Studies | Deletion and substitution analogues of melittin peptide |
KR100361933B1 (ko) * | 1993-09-08 | 2003-02-14 | 라 졸라 파마슈티칼 컴파니 | 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트 |
US5519114A (en) * | 1993-10-29 | 1996-05-21 | University Of Florida Research Foundation, Inc. | Retroviral superantigens, superantigen peptides, and methods of use |
CA2155762C (en) * | 1994-08-23 | 2000-04-25 | Haruya Sato | Protein modification method |
WO1998056400A1 (en) * | 1997-06-11 | 1998-12-17 | Board Of Regents, The University Of Texas System | Anti-inflammatory and other therapeutic, prophylactic or diagnostic uses of synthetic melittin and new related peptides |
US6372471B1 (en) * | 1998-10-01 | 2002-04-16 | The Rockefeller University | Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
CA2441476A1 (en) * | 2001-03-02 | 2002-09-12 | The Rockefeller University | Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
US7538083B2 (en) * | 2003-11-05 | 2009-05-26 | Intercell Ag | Compositions and methods for the potentiation of immune responses against target antigens |
WO2007099387A1 (en) * | 2006-03-03 | 2007-09-07 | Mymetics Corporation | Virosome-like vesicles comprising gp41-derived antigens |
EP1938835A1 (de) * | 2006-12-29 | 2008-07-02 | Pevion Biotech AG | Nichtspezifische immunostimulierende Wirkstoffe |
-
2004
- 2004-11-05 US US10/983,169 patent/US7538083B2/en not_active Expired - Fee Related
- 2004-11-05 CA CA002543072A patent/CA2543072A1/en not_active Abandoned
- 2004-11-05 AU AU2004291277A patent/AU2004291277A1/en not_active Abandoned
- 2004-11-05 EP EP04818758A patent/EP1680446B1/de not_active Not-in-force
- 2004-11-05 DE DE602004009818T patent/DE602004009818T2/de active Active
- 2004-11-05 WO PCT/EP2004/012548 patent/WO2005049647A2/en active IP Right Grant
- 2004-11-05 AT AT04818758T patent/ATE377023T1/de not_active IP Right Cessation
-
2006
- 2006-06-02 NO NO20062579A patent/NO20062579L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2543072A1 (en) | 2005-06-02 |
US7538083B2 (en) | 2009-05-26 |
WO2005049647A3 (en) | 2005-08-11 |
DE602004009818T2 (de) | 2008-09-18 |
EP1680446B1 (de) | 2007-10-31 |
EP1680446A2 (de) | 2006-07-19 |
ATE377023T1 (de) | 2007-11-15 |
DE602004009818D1 (de) | 2007-12-13 |
US20050196383A1 (en) | 2005-09-08 |
AU2004291277A1 (en) | 2005-06-02 |
WO2005049647A2 (en) | 2005-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20062579L (no) | Preparater som omfatter melittin-avledede peptider og fremgangsmate for styrking av immunresponser mot malantigener | |
ATE426412T1 (de) | Adjuvante influenza-vakzine | |
WO2007067681A3 (en) | Immunostimulatory compositions and methods | |
BRPI0708344B8 (pt) | vetores adenovirais quiméricos e composição imunogênica | |
BR0313587A (pt) | composições imunoestimuladoras e métodos de estimulação de uma resposta imune | |
EA200701305A1 (ru) | Иммуногенные композиции, содержащие циклические пептиды, полученные из бета-амилоидного пептида | |
ATE419008T1 (de) | Adjuvante zusammensetzung und anwendungsverfahren dafür | |
MX2007002787A (es) | Adyuvante de glicosilceramida para antigenos de sacarido. | |
EA201000491A1 (ru) | Аминометилзамещенные тетрациклиновые соединения | |
EA200802170A1 (ru) | Лиофилизированная композиция терапевтического пептидного антитела | |
DK1682530T3 (da) | Pyrrolsubstituerede indoler som inhibitorer af PAI-1 | |
CR10530A (es) | Anticuerpos anti-dlla4 y metodos que los usan | |
WO2007047764A3 (en) | Wt1 hla class ii-binding peptides and compositions and methods comprising same | |
DK1487485T3 (da) | Imidazoquinolinadjuvanser til DNA-vacciner | |
PL375398A1 (en) | Immunostimulatory nucleic acids | |
WO2007120673A3 (en) | Immunogenic wt-1 peptides and methods of use thereof | |
EA201000424A1 (ru) | Антитела к il-23 | |
MA32388B1 (fr) | Immunomodulation par des inhibiteurs d'iap | |
NO20084320L (no) | Antistoffer mot EGFL7 og fremgangsmater for anvendelse av disse | |
EA200900738A1 (ru) | Слитые белки, содержащие антигены отторжения опухоли ny-eso-1 и lage-1 | |
WO2007016715A3 (en) | Immune response inducing preparations | |
DK1589834T3 (da) | Enteral komposition til forebyggelse og/eller behandling af sepsis | |
ATE356867T1 (de) | Epitopen aus dem epha2-antigen | |
EA201200538A1 (ru) | Арабиногалактан для повышения приобретенного иммунного ответа | |
WO2006095176A3 (en) | Vaccine formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |